Asthma, Exercise-Induced
11
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
45%
5 trials in Phase 3/4
50%
4 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (11)
A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma
Exercise Induced Bronchoconstriction (0476-359)
Adaptation to Ozone in Individuals With Asthma/Exercise-induced Bronchoconstriction
To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol
Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)
Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)
Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)
The Effect of Physical Exercise in a Cold Air Environment on Normal Volunteers and Asthmatic Patients
Do Heat and Moisture Exchange Mask Reduce EIB and Cough Severity in Asthma
The Effect of Benralizumab on Exercise-induced Bronchoconstriction
Pulmonary Disorders During Exercise in Patients With Obstructive Sleep Apnea